Aldesleukin Completed Phase 2 Trials for Metastatic Melanoma / Skin Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00665470Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma
NCT00910650Study of Gene Modified Immune Cells in Patients With Advanced Melanoma
NCT00314106Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic Melanoma